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■ Abstract Real-time polymerase chain reaction (PCR) is commonly used
for a sensitive and specific quantification of messenger RNA (mRNA). The
levels of mRNA are frequently compared between two or more experimen-
tal groups. However, such comparisons require normalization procedures,
and reference genes are frequently used for this purpose.We discuss pitfalls
in normalization and specifically in the choice of reference genes.Reference
genes,which prove suitable for some experimental conditions,are not nec-
essarily similarly appropriate for others.Therefore,a proper validation ofthe
suitability of a given reference gene or sets thereof is required for each ex-
perimental setting.Several computer programmes are available to aid such
validation.
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Gene expression analysis at the messenger RNA
(mRNA) level has become increasingly important in bi-
ological research. Originally, it was mainly used to de-
termine whether differences protein expression could
be explained at the transcriptional level. However, it
meanwhile has much wider applications. This includes
measurement of mRNA in situations where quantifica-
tion of the protein is difficult or cumbersome, e.g. the
measurement of atrial natriuretic peptide mRNA as a
marker of the hypertrophic phenotype of cardiomy-
ocytes,but important findings continue to require con-
firmation at the protein level. Most recently, mRNA ex-
pression analysis is being used to provide insight into
complex regulatory networks and to identify genes rele-
vant to new biological processes or implicated in dis-
eases. Although differences in measured mRNA levels
can result from differential mRNA degradation,they are
usually interpreted to reflect differential transcription.
In this issue of Basic Research in Cardiology Brattelid et
al.[1] highlight the problem of normalization using ref-
erence genes when measuring the regulation of gene ex-
pression at the mRNA level.
Normalization is a widely used approach when com-
paring the levels of lipids, proteins or mRNA in two or
more groups of samples. Actually, it is being used so
widely and routinely that the underlying assumptions
are often ignored which can lead to dubious results and
conclusions. For example, after myocardial infarction
the amount of fibroblasts and extracellular matrix pro-
teins is increased relative to cardiomyocytes in the my-
ocardium.Comparing the diseased with the normal tis-
sue might lead to false results and wrong conclusions
when normalizing for the amount of tissue or for total
protein content because the differences in cell type and
amount of extracellular matrix proteins are not taken
into account. Therefore, it is always important to be
aware ofthe assumptions underlying normalization and
of the implications of such,often untested assumptions
for data interpretation.
Apart from general considerations regarding the
normalization of data in biology,special considerations
apply to the normalization of quantitative real-time
polymerase chain reaction (PCR) data [4]. While nor-
malization for sample size,e.g.tissue volume or weight,
can also be applied to real-time PCR data,this is only a
first but on its own insufficient step as it can be difficult
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to ensure that different samples contain the same cellu-
lar material (see example above). Measuring total RNA
or genomic DNA gives a good idea of the amount of cel-
lular material. Normalization against genomic DNA is
rarely used since it is difficult to coextract with RNA and
it may vary in copy number per cell. Total RNA mea-
surement is a good second step to control for experi-
mental error,but it requires a good method of assessing
quality and quantity. The measurement can be effected
when RNA quality is suboptimal [2]. The drawback of
normalization against total RNA is that it does not con-
trol for errors introduced at the reverse transcription
step of PCR reactions.In addition,it primarily measures
ribosomal RNA (rRNA) whereas real-time PCR aims to
determine mRNA expression.Furthermore,normaliza-
tion for total RNA assumes that the rRNA:mRNA ratio is
the same in all groups, which might not always be the
case [9].Finally,rRNA is not present in purified mRNA
and the high abundance of rRNA compared to mRNA
makes it difficult to subtract the baseline value in real-
time PCR analysis. Thus, markers of rRNA such as 18S
or 28S rRNA might also be suboptimal as normalization
factors in many settings.
Therefore,the most frequently used approach in real-
time PCR is to normalize the expression level of a spe-
cific mRNA of interest against that of one or more refer-
ence genes [4]. This is based on the assumption that
expression of the mRNA of interest is described relative
to the overall transcriptional activity of a cell.Reference
genes are often referred to as housekeeping genes as-
suming that those genes are expressed at a constant level
in various tissues at all stages of development and are
unaffected by the experimental treatment. The most
commonly used reference genes are β-actin,glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH), hypoxan-
thine phosphoribosyltransferase (HPRT), and β-2-mi-
croglobulin. Normalization to a reference gene is a
simple method and frequently used because it can con-
trol many variables.An advantage of reference genes as
compared to total or rRNA is that the reference gene is
subject to the same conditions as the mRNA of interest.
Both the reference gene and the gene ofinterest are mea-
sured using real-time PCR which simplifies the normal-
ization, particularly if the number of amplification cy-
cles during the PCR reaction is similar for the reference
gene and the gene of interest.The reference gene might
also be used as a control for different amounts of RNA
used in the reverse transcription step, but this requires
validation. Most classical reference genes (see above)
have been introduced for normalization purposes when
mRNA expression was assessed by methods such as
Northern blotting and conventional endpoint reverse
transcriptase PCR because of their high expression lev-
els in all cells.For these techniques their use as positive
control was acceptable,because only qualitative or semi-
quantitative changes were measured.
Real-time PCR provides high sensitivity and accurate
mRNA quantification over a wide dynamic range of de-
tection.This requires re-evaluation of the usefulness of
previously used reference genes,but many studies con-
tinued to use the above mentioned classical reference
genes for normalization without any validation of their
suitability in real-time PCR. This potentially calls for
trouble,as it has recently been found that the mRNA ex-
pression level of several reference genes is much less sta-
ble than one would hope.Several studies have reported
that the expression levels of the classical reference genes
can vary extensively and are thus unsuitable for the nor-
malization.Moreover,several recent studies report that
such variation may by due to active regulation of classi-
cal reference genes under certain experimental condi-
tions (see: http://normalisation.gene-quantification.
info).
For example,variation in supposedly stable reference
genes was shown in studies examining their expression
in serum-stimulated fibroblasts [8].In that study the ex-
pression levels of β-actin and GAPDH were increased
whereas that of β-2 microglobulin was unaffected by
serum when normalizing for amount of mRNA. Com-
paring 13 reference genes in tumour samples from dif-
ferent tissues HPRT was identified to be the best refer-
ence gene for normalization whereas β-2 microglobulin
was unsuitable [5].Another study demonstrates the ac-
tive regulation of HPRT,β-actin and two other reference
genes (hydroxymethylbilane synthase and peptidylpro-
lyle isomerase B) during lymphocyte activation [7].
If inappropriate reference genes are used for normal-
ization, the experimental results obtained can differ
greatly from those using a validated reference gene.An
example is the study of mRNA levels of IL-4 in whole
blood from healthy volunteers and patients with tuber-
culosis (TB) before and after 6 months anti-TB treat-
ment,in which normalization was performed with both
GAPDH  and a reference gene specifically validated for
that condition, HuPO [3]. The increase of IL-4 expres-
sion in TB patients when normalized to HuPO disap-
peared using GAPDH for normalization, whereas the
non-significant decrease in IL-4 after anti-TB treatment
normalized for HuPO turned into a significant increase
when GAPDH was used for normalization. Conse-
quently, both false positive and false negative results
may be obtained when using an inappropriate reference
gene.Importantly,a suitable reference gene in some cir-
cumstances is not necessarily similarly appropriate in
others.Therefore,it is important to validate whether the
chosen reference genes can be used for accurate gene ex-
pression analysis in a specific experimental condition.
Validation ofa reference gene requires removal ofany
non-specific variation in expression.This can be done us-
ing a recently introduced programme called geNorm
(freely available at http://medgen.ugent.be/~jvdesomp/
genorm/) that mathematically identifies the most suit-
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able reference gene for a given experimental condition
[10]. Its calculations use the geometric mean of the ex-
pression ofthe candidate genes and by elimination ofthe
least stable control genes the two most stable control
genes are identified.Other statistical programmes (Best-
Keeper,Norm Finder) have also been developed to deter-
mine the most appropriate reference gene for a given ex-
perimental condition. They use different algorithms to
analyse the variation in the expression ofreference genes,
and that may result in different recommendations for the
most suitable reference gene.Independent ofthe calcula-
tion method being used,pairs of reference genes appear
to yield more robust data than any single reference genes
in many cases.Thus,all three programmes identified the
same combination of two reference genes as being most
suitable for normalization [6].
In conclusion,real-time PCR is a powerful technique
for the quantitative analysis of mRNA levels but reliable
results can only be obtained when using appropriate
normalization procedures. In this regard, reference
genes appear superior to total RNA or rRNA for nor-
malization purposes. However, the reference gene of
choice may differ between experimental conditions and,
therefore,validation of the reference gene being used is
required for any given setting. Because of the inherent
variation in the expression of reference genes the use of
multiple reference genes rather than one reference gene
is recommended to ensure reliable normalization of
real-time PCR [10]. Several statistical programmes can
help to determine the most appropriate reference gene
or set of genes.
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